SARS-CoV-2 Infection Clinical Trial
Official title:
Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel
The objective of the study is to determine the percentage of past SARS-CoV-2 infections in hospital health personnel involved in the care of people with COVID-19 in HUGTiP and in Badalona Serveis Assistencials de Badalona.
Health personnel, especially hospital workers, have been a group especially affected by the
COVID-19 epidemic. According to data from the Ministry of Health, in Spain 26% of health
personnel have been infected by COVID-19, for a total of 31,053 professionals, representing
up to 18.5% of all infections in the Spanish state, with variations between the different
autonomous communities.1 In Italy it was estimated that up to 20% of health workers who
responded to the epidemic would have been infected within a month.
There are no unified guidelines at the state level to determine infection prevention
strategies in health personnel in order to validate them, beyond the use of Personal
Protective Equipment (PPE) in personnel and general strategies for isolation and prevention
of transmission.
There are no approved drug prevention strategies for primary prophylaxis against COVID-19.
Currently, there are no universal mass screening strategies (virological or immunological) to
estimate the actual number of health personnel with an asymptomatic infection, as well as to
determine the percentage of personnel who have already passed the infection asymptomatically
or to determine the percentage of personnel A healthcare provider who has developed some form
of immunity following a confirmed COVID-19 infection.
The HUGTiP, like the rest of Catalan hospitals, has suffered a massive avalanche accumulated
in the time of admission by COVID-19, which has forced it to adopt different innovative
strategies to visit them in emergencies, enter them in conventional hospitalization in a
conventional plant, or attend them in the intensive care units that had to be created de novo
against the clock. As of April 20, 2020, 1,000 hospital discharges have been granted to
patients admitted by COVID-19 in conventional hospitalization plants and 170 more discharges
from those admitted to intensive care units at HUGTiP. Likewise, the Municipal Hospital of
Badalona has given a total of 300 discharges of patients with COVID-19, and they have also
reported about 180 infections in their health personnel in this period.
Due to the high transmission rate of SARS-CoV-2 and its potential severity, several
healthcare workers at HUGTiP decided on their own to take empirical primary prophylaxis with
oral hydroxychloroquine individually as prevention of SARS-CoV-2 infection.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04555096 -
A Trial of GC4419 in Patients With Critical Illness Due to COVID-19
|
Phase 2 | |
| Completed |
NCT04593641 -
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)
|
Phase 1 | |
| Recruiting |
NCT05200754 -
Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19
|
Phase 2 | |
| Completed |
NCT04583995 -
A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom
|
Phase 3 | |
| Recruiting |
NCT06255860 -
SARS-COV-2 Reinfection and Multisystem Inflammatory Syndrome in Children (MIS-C) Risk: Matched Case-control Study
|
||
| Recruiting |
NCT04516811 -
Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19
|
Phase 3 | |
| Recruiting |
NCT05012826 -
Osteopathy and Physiotherapy Compared to Physiotherapy Alone on Fatigue and Functional Status in Long COVID
|
N/A | |
| Completed |
NCT05007236 -
Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.
|
Phase 2 | |
| Recruiting |
NCT06026514 -
Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
|
Phase 1 | |
| Completed |
NCT05523739 -
Safety and Efficacy Study of STI-1558 in Healthy Adults and SARS-CoV-2-Positive Patients
|
Phase 1 | |
| Suspended |
NCT04738136 -
Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia
|
Phase 2 | |
| Recruiting |
NCT04584658 -
Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
|
||
| Recruiting |
NCT04547114 -
Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects
|
||
| Completed |
NCT05119348 -
Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments
|
N/A | |
| Completed |
NCT05096962 -
COVID-19: SARS-CoV-2-CZ-PREVAL-II Study
|
||
| Recruiting |
NCT04534400 -
Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure
|
||
| Completed |
NCT04527354 -
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia
|
Phase 2 | |
| Completed |
NCT04583982 -
ImmuneSense™ COVID-19 Study
|
||
| Completed |
NCT05077176 -
Phase 3 Booster Vaccination Against COVID-19
|
Phase 3 | |
| Completed |
NCT05584189 -
COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability
|
N/A |